BCG Vaccine Derived Peptides Induce SARS-CoV-2 T Cell Cross-Reactivity

Epidemiological studies and clinical trials suggest Bacillus Calmette-Guérin (BCG) vaccine has protective effects against coronavirus disease 2019 (COVID-19). There are now over 30 clinical trials evaluating if BCG vaccination can prevent or reduce the severity of COVID-19. However, the mechanism by...

Descripción completa

Detalles Bibliográficos
Autores principales: Eggenhuizen, Peter J., Ng, Boaz H., Chang, Janet, Fell, Ashleigh L., Cheong, Rachel M. Y., Wong, Wey Y., Gan, Poh-Yi, Holdsworth, Stephen R., Ooi, Joshua D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8374943/
https://www.ncbi.nlm.nih.gov/pubmed/34421902
http://dx.doi.org/10.3389/fimmu.2021.692729

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8374943/
https://www.ncbi.nlm.nih.gov/pubmed/34421902
http://dx.doi.org/10.3389/fimmu.2021.692729

Ejemplares similares